This article was first published by The Cannigma and is re-posted with permission.
The majority of seriously ill COVID-19 patients given CBD to calm inflammation were released from the hospital in under a month, in a trial conducted recently at an Israeli hospital.
The initial findings, stated an announcement by Beilinson Hospital in Petach Tikvah, Israel, indicate that CBD “has a positive impact on a number of inflammatory markers that occur with Corona patients.”
A cytokine storm, the body’s overreaction to infection, contributes to the mortality of COVID-19 patients, the announcement explained. This study was meant to test the efficacy and safety of CBD in reducing that “turbulent inflammatory process.”
The cannabinoids in cannabis can modulate the body’s immune responses through their interaction with the endocannabinoid system.
Of the 11 patients in the trial, eight were released from hospital within 7-30 days, though the other three participants died from COVID-19 complications.
To read the full article, click here.
- Israeli Researchers Say Medical Cannabis Could Effectively Treat Some COVID-19 Symptoms
- Israeli Researchers Tout ‘1st Clinical Evidence’ That Controlled Doses Of Cannabis Relieve Pain